Series E - Cartiva

Series E - Cartiva

Investment Firm

Overview

Cartiva is a developer of innovative products for the treatment of cartilage injuries and osteoarthritis.

Announced Date

Jan 10, 2017

Funding Type

Series E

Highlights

Location

United States, North America

Social

Investor Lead

New Enterprise Associates

New Enterprise Associates

New Enterprise Associates is a convertible_note and debt and early_stage_venture and late_stage_venture and post_ipo and venture firm.

Participant Investors

2

Investor Name
Participant InvestorWindham Venture Partners
Participant InvestorNew Enterprise Associates

Round Details and Background

Cartiva raised $8500000 on 2017-01-10 in Series E

Cartiva is a developer of innovative products for the treatment of cartilage injuries and osteoarthritis.

Company Funding History

6

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
May 11, 2015
Series D - Cartiva
2-8.5M
Dec 29, 2014
Venture Round - Cartiva
-1.5M
Jan 08, 2014
Debt Financing - Cartiva
1-1.5M
Jul 15, 2013
Series A - Cartiva
2-4.3M

Recent Activity

There is no recent news or activity for this profile.